$109.05
—
AUM
$334M
NAV
—
Expense Ratio
—
Yield
0.92%
52W High
$110.81
52W Low
$78.77
The State Street SPDR S&P Pharmaceuticals ETF (the "Fund") seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S.
Top Holdings (50)
| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | State Street Navigator Securities Lending Portfolio II | — | 6.6607% |
| 2 | Axsome Therapeutics Inc | — | 2.2796% |
| 3 | Nuvation Bio Inc | — | 2.1291% |
| 4 | Xeris Biopharma Holdings Inc | — | 2.1072% |
| 5 | MBX Biosciences Inc | — | 2.0388% |
| 6 | EyePoint Inc | — | 2.0357% |
| 7 | Eli Lilly & Co | — | 2.0150% |
| 8 | Mind Medicine MindMed Inc | — | 2.0149% |
| 9 | Merck & Co Inc | — | 2.0087% |
| 10 | Supernus Pharmaceuticals Inc | — | 2.0058% |
| 11 | Viatris Inc | — | 1.9995% |
| 12 | Zoetis Inc | — | 1.9853% |
| 13 | Elanco Animal Health Inc | — | 1.9793% |
| 14 | Liquidia Corp | — | 1.9661% |
| 15 | Bristol-Myers Squibb Co | — | 1.9623% |
| 16 | Edgewise Therapeutics Inc | — | 1.9473% |
| 17 | Amneal Pharmaceuticals Inc | — | 1.9225% |
| 18 | Jazz Pharmaceuticals PLC | — | 1.9198% |
| 19 | Perrigo Co PLC | — | 1.9181% |
| 20 | Pacira BioSciences Inc | — | 1.9147% |
| 21 | Ligand Pharmaceuticals Inc | — | 1.9140% |
| 22 | Rapport Therapeutics Inc | — | 1.8857% |
| 23 | Indivior PLC | — | 1.8855% |
| 24 | Royalty Pharma PLC | — | 1.8815% |
| 25 | Tarsus Pharmaceuticals Inc | — | 1.8758% |
| 26 | Prestige Consumer Healthcare Inc | — | 1.8730% |
| 27 | Avadel Pharmaceuticals PLC | — | 1.8690% |
| 28 | Johnson & Johnson | — | 1.8666% |
| 29 | Organon & Co | — | 1.8604% |
| 30 | Phathom Pharmaceuticals Inc | — | 1.8314% |
| 31 | Harrow Inc | — | 1.8184% |
| 32 | Innoviva Inc | — | 1.8060% |
| 33 | Crinetics Pharmaceuticals Inc | — | 1.8044% |
| 34 | Esperion Therapeutics Inc | — | 1.7997% |
| 35 | Pfizer Inc | — | 1.7994% |
| 36 | ANI Pharmaceuticals Inc | — | 1.7928% |
| 37 | Harmony Biosciences Holdings Inc | — | 1.7752% |
| 38 | Collegium Pharmaceutical Inc | — | 1.7653% |
| 39 | Maze Therapeutics Inc | — | 1.7312% |
| 40 | Amylyx Pharmaceuticals Inc | — | 1.7010% |
| 41 | Terns Pharmaceuticals Inc | — | 1.6871% |
| 42 | Omeros Corp | — | 1.6731% |
| 43 | Arvinas Inc | — | 1.6680% |
| 44 | CorMedix Inc | — | 1.6462% |
| 45 | Trevi Therapeutics Inc | — | 1.6460% |
| 46 | Amphastar Pharmaceuticals Inc | — | 1.6392% |
| 47 | Phibro Animal Health Corp | — | 1.6190% |
| 48 | WaVe Life Sciences Ltd | — | 1.5655% |
| 49 | Ocular Therapeutix Inc | — | 1.4676% |
| 50 | Nektar Therapeutics | — | 1.3641% |
Last synced May 26, 2026, 5:18 PM · Price and AUM from Yahoo Finance · Holdings from SEC N-PORT filings